Cancer Research UK has deepened its commitment to good research practice by becoming a signatory of the Concordat to support research integrity
We’re proud to be the Expert Partners for ‘Cancer Revolution: Science, innovation and hope’, which will open its doors in October 2021 at Manchester’s Science and Industry Museum, before relocating to the Science Museum in London in March 2022.
LGBTQ+ communities experience inequalities throughout their cancer journey, including in screening and diagnosis, clinical care, communication and overall experience. Find out about the barriers the community faces and the commitments required to improve cancer care for LGBTQ+ people.
Cancer Research UK scientists are developing tests that can detect the presence of glioma, a type of brain tumour, in patient urine or blood plasma.
The National Institute of Health and Care Excellence (NICE) has approved the use of pemigatinib in adults with a rare type of bile duct cancer that has continued to advance or spread after initial chemotherapy.
Cancer Research UK’s Annual Report and Accounts 2020/21 reveals the impact of the pandemic on its income and spend on charitable activities over the past year.
A Cardiff University-led UK-wide survey has found that more than 1 in 5 people are less likely to take part in cancer screening than before the pandemic.